PACIRA BIOSCIENCES IN

Pacira BioSciences Announces Closing of $375 Million Five-Year Term Loan B

09 Dec 2021 07:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL® and iovera° of $48.0 Million for November 2021

07 Dec 2021 07:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

23 Nov 2021 07:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Completes Acquisition of Flexion Therapeutics and Strengthens Leadership Position in Non-Opioid Pain Management

19 Nov 2021 07:40:10 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at the Jefferies London Healthcare Conference

10 Nov 2021 07:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $44.3 Million for October 2021

09 Nov 2021 07:00:02 By Nasdaq GlobeNewswire

Pacira Files Lawsuit Against eVenus for Patent Infringement

08 Nov 2021 15:30:14 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Third Quarter 2021 Financial Results

03 Nov 2021 07:00:03 By Nasdaq GlobeNewswire

Pacira Receives Notice of Allowance for New Patent Covering EXPAREL Composition

02 Nov 2021 06:30:00 By Nasdaq GlobeNewswire

Pacira to Report Third Quarter 2021 Financial Results on Wednesday November 3, 2021

27 Oct 2021 06:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences to Acquire Flexion Therapeutics Further Expanding Leadership Position in Non-Opioid Pain Management

11 Oct 2021 06:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences to Host Investor Day on October 15th, 2021 in Tampa, FL

08 Oct 2021 07:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Notified of Abbreviated New Drug Application Filing for EXPAREL®

04 Oct 2021 06:30:00 By Nasdaq GlobeNewswire

Pacira Announces Commercial Production Underway with Enhanced EXPAREL Manufacturing Process at Swindon Facility

30 Sep 2021 06:30:00 By Nasdaq GlobeNewswire

Pacira Announces Publication of Phase 3 Study of EXPAREL Infiltration in Pediatric Patients Undergoing Spinal or Cardiac Surgeries

21 Sep 2021 06:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $42.3 Million for August 2021

15 Sep 2021 06:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

08 Sep 2021 07:00:04 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $42.1 Million for July 2021

10 Aug 2021 07:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 2021 Wedbush PacGrow Healthcare Virtual Conference

04 Aug 2021 07:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021

03 Aug 2021 07:00:03 By Nasdaq GlobeNewswire